20.84 USD
▼-0.06-0.29%
盘后 21.10 0.00%
2026-09-15
市值
$1.53B
市盈率
4.92
EPS
4.31
股息率
—
52 周区间
16.52 – 25.15
成交量
1.10M
Beta
0.34
目标价
35.00
52W 低 16.5252W 高 25.15
价格走势
公司简介
Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally. Its royalty portfolio includes RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol, and an inhaled corticosteroid, and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, and ABA, VI. The company also markets GIAPREZA for increasing blood pressure in adults with septic or other distributive shock; XACDURO, a co-packaged for intravenous use ...